Daptomycin associated eosinophilic pneumonia

Med Clin (Barc). 2021 Feb 12;156(3):148-149. doi: 10.1016/j.medcli.2019.10.015. Epub 2020 Feb 22.

[Article in English, Spanish]

Authors

Raquel Fernández-González¹, María Dolores Díaz López², Ana María Lorenzo Vizcaya³, Amara González Noya³

Affiliations

¹ Servicio de Medicina Interna, Hospital Universitario de Ourense, Ourense, España. Electronic address: raquelferngonz@gmail.com.
² Unidad de Infecciosas, Servicio de Medicina Interna, Hospital Universitario de Ourense, Ourense, España.
³ Servicio de Medicina Interna, Hospital Universitario de Ourense, Ourense, España.

PMID: 32098706
DOI: 10.1016/j.medcli.2019.10.015

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / adverse effects
Daptomycin* / adverse effects
Humans
Pulmonary Eosinophilia* / chemically induced
Pulmonary Eosinophilia* / diagnosis

Substances

Anti-Bacterial Agents
Daptomycin